Jarrell B E, Szentpetery S, Mendez-Picon G, Lee H M, Greenfield L J
Arch Surg. 1981 Jul;116(7):930-2. doi: 10.1001/archsurg.1981.01380190060013.
Renal transplant patients in whom deep vein thrombosis and pulmonary embolism (PE) develop usually respond to heparin sodium treatment. A small percentage of transplant patients will require vena caval filter placement to prevent recurrent PE, and this report details our experience with two patients. In one patient there was contraindication to heparin, and in the other, a massive recurrent PE. Greenfield filters were inserted transvenously in these patients and found to be well tolerated. There was no evidence of renal compromise, recurrent PE, or other complications. Follow-up venograms confirmed the presence of patent vena cavas with properly positioned filtered. Autopsy studies subsequently performed confirmed the clinical assessment of each patient's course, and neither patient died of recurrent embolism.
发生深静脉血栓形成和肺栓塞（PE）的肾移植患者通常对肝素钠治疗有反应。一小部分移植患者需要放置腔静脉滤器以预防复发性PE，本报告详细介绍了我们对两名患者的治疗经验。一名患者有肝素使用禁忌证，另一名患者发生了大面积复发性PE。在这些患者中经静脉插入了格林菲尔德滤器，发现耐受性良好。没有肾损害、复发性PE或其他并发症的证据。随访静脉造影证实腔静脉通畅且滤器位置正确。随后进行的尸检研究证实了对每名患者病程的临床评估，两名患者均未死于复发性栓塞。
